CVRX CVRx, Inc. Common Stock

XNAS 6.35 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CVRX $6.35 —
Key stats
$6.35
52-Week Range
$1.25 – $11.30
YTD
-10.56%
Straddle Price
$8.90
P/C Vol Ratio
0.00
Market Cap
$0.0B
Open
$1.37
Day Range
$1.30 – $1.47
Volume
199,851
Prev Close
$1.37
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.12%
Beta vs SPY1.07
Cost of Equity (CAPM)11.02% (VRP-adj)
WACC7.51%
Volatility Risk Premium+635.5pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+6.9%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.07 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-260.4%
Book / Price55.4% — banking bias active (P/B is primary)
Gross Margin (TTM)86.9%
FCF Margin (TTM)-67.1%
Debt / Equity2.94
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$2.44 (Market Anchor value)
SMA 20 / Bollinger Mid$1.66
Bollinger Width / SMA206246.1% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: BAX, BDX, BSX, MDLN, SOLV, SYK (SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
55%
20-Day Fair Value
≈ by Nov 23, 2026
ACTIVE
$1.43
α +0.6% rank 99%
conviction
41%
40-Day Fair Value
≈ by Dec 22, 2026
ACTIVE
$1.42
α +0.1% rank 99%
conviction
3%
60-Day Fair Value
≈ by Jan 20, 2027
ACTIVE
$1.44
α +1.5% rank 99%
conviction
55%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 30.6× · 5 peers
Peer EV/EBITDA n/a 0% median 18.4× · 6 peers
Peer P/B $1.99 16% median 2.6× · 6 peers
Peer P/S $5.38 16% median 2.2× · 6 peers
Market Anchor (SMA50) $2.44 69% stability 85% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-23 · updated
About
Industry (SIC)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
223
List Date
2021-06-30
CIK
0001235912
Next Earnings
2026-11-04 (After-Close)
EPS Forecast
($0.49) (3 est.)
Headquarters
Minneapolis, MN
Homepage
https://www.cvrx.com

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan---32.90%-18.85%-17.61%17.67%-3.52%-11.04%
Feb--7.86%-33.13%-21.48%-16.17%14.61%-9.66%
Mar---30.11%-14.42%-12.41%-0.97%15.09%-8.56%
Apr---0.95%28.34%-13.69%-41.58%-17.47%-9.07%
May--2.31%-1.80%-31.32%-8.98%-29.99%-13.96%
Jun0.00%2.91%23.22%78.69%-9.26%-5.34%15.04%
Jul-24.28%44.28%16.43%-26.99%31.79%-5.82%5.90%
Aug-14.68%-16.09%-6.06%18.80%3.84%-46.18%-10.06%
Sep-14.17%29.40%-12.31%-2.65%4.40%-42.43%-6.29%
Oct0.00%4.46%-10.74%51.33%28.02%-7.19%*10.98%
Nov-32.04%30.73%50.40%14.33%-5.31%--11.62%
Dec8.61%27.25%43.43%-18.36%-24.47%--7.29%
Total-59.07%43.60%33.19%-28.41%-38.34%-81.15%-21.70%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.60
SMA 50: $2.41
SMA 200: $5.43
Current: $1.42
EMA 12: $1.48
EMA 26: $1.83
MACD: -0.3517 | Signal: 0.0437
BEARISH
ADX (14): 42.65
STRONG TREND
+DI: 13.06
−DI: 36.07

Momentum Oscillators

RSI (14): 30.48
NEUTRAL
Stoch %K: 26.07
Stoch %D: 22.65
Williams %R: -67.33

Volume & Volatility

BB Upper: $2.32
BB Lower: $0.87
NEUTRAL
OBV: -3,544,347
Vol SMA 20: 723,288
Vol ROC: -49.88%
ATR: $0.17
True Range: $0.17
HV 20: 160.0%
HV 30: 136.1%
HV 60: 216.5%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-25T00:00:00 – 2026-10-23T00:00:00
AI Analysis

LLM Stock Analysis Report: CVRX

Executive Summary

Executive Summary: BEARISH (Confidence Level: 7/10)

Key drivers: Negative news sentiment, oversold technical indicators, high volatility.

Primary risks: Regulatory issues, negative earnings surprises, market correction.

2-3 sentence investment thesis: CVRX is trading near historic lows due to persistent negative news and oversold technical conditions. While the stock has shown resilience in the past, the current situation presents a higher risk profile, making it challenging for investors to justify a long position.

Recent news sentiment impact: The recent slew of negative headlines has contributed significantly to the bearish tone, with investors reacting negatively to potential regulatory hurdles and sales execution concerns.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): BEARISH; Medium-term (1-3 months): NEUTRAL; Long-term (3-12 months): BULLISH

Support/Resistance Levels:

  • SMA 20: $5.04 (resistance)
  • SMA 50: $5.21 (resistance)
  • SMA 200: $7.22 (support)

Momentum Signals:

  • RSI interpretation: Oversold (25.84 <30), indicating potential buy signal.
  • MACD signal: Bearish momentum, with a negative histogram (-0.08).
  • Bollinger Bands position: Oversold, indicating a mean reversion potential.

Volume Analysis: Volume trends and institutional interest signals:

  • On-Balance Volume (OBV): Positive volume flow, indicating buying pressure.
  • Average True Range (ATR): $0.59, reflecting increased volatility.
  • Volume Rate of Change: 1301.08%, suggesting high turnover.

News & Sentiment Analysis

Recent Headlines Summary: Negative headlines dominate, emphasizing regulatory issues and sales execution concerns.

Sentiment Assessment: NEGATIVE (Based on recent news articles)

Catalyst Identification: None evident in the near term; however, a potential product launch could bring positive momentum.

Market Narrative: The negative news sentiment has created a bearish narrative, which is currently driving market action.

Risk & Volatility Assessment

Beta Interpretation: High risk relative to the market (beta: 1.02 >1).

Volatility Regime: Current volatility is above average, with a HV30 of 280.6%.

Options Market Signals: IV rank: 43.2% (Medium), indicating moderate volatility.

Downside Protection: Support levels are present at SMA 20 and SMA 50; however, the stock's high beta suggests increased risk.

Market Context & Positioning

Sector Performance: CVRX is underperforming its sector peers.

Institutional Activity: Institutional interest is mixed, with some buyers entering the market while others take profits.

Correlation Analysis: CVRX has a moderate correlation (0.13) with the broader market, indicating amplification of market movements.

Relative Valuation: The stock is trading at a discount relative to its peers and historical averages.

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $5.04 (resistance)
  • SMA 50: $5.21 (resistance)

Breakout/Breakdown Levels:

  • SMA 200: $7.22 (support)

Time-Sensitive Catalysts: No imminent catalysts, but a potential product launch could bring positive momentum.

Risk Management: Stop-loss levels should be set at SMA 20 and SMA 50; position sizing considerations should prioritize risk management.

Please note that the analysis is based on the provided data and may not reflect the actual stock performance. The report aims to provide an objective, structured assessment of the stock's technical and fundamental conditions.

Generated
Earnings History
10 of 16 under expected move
Avg Expected Move
35.41%
Avg Actual Move
16.91%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2022-11-01 After-Close 20.52% 1.12% 0.05x Within
2023-01-09 After-Close 37.19% 3.12% 0.08x Within
2023-04-27 After-Close 10.55% 22.78% 2.16x Exceeded
2023-07-25 After-Close 25.15% 5.43% 0.22x Within
2023-10-26 After-Close 13.63% 2.41% 0.18x Within
2024-01-08 After-Close 12.13% 0.32% 0.03x Within
2024-04-30 After-Close 17.73% 34.75% 1.96x Exceeded
2024-07-29 After-Close 29.40% 14.51% 0.49x Within
2024-10-29 After-Close 22.58% 31.01% 1.37x Exceeded
2025-02-04 After-Close 29.38% 7.20% 0.25x Within
2025-05-08 After-Close 20.24% 38.69% 1.91x Exceeded
2025-08-04 After-Close 29.80% 9.87% 0.33x Within
2025-11-05 After-Close 41.11% 2.66% 0.06x Within
2026-02-12 After-Close 181.02% 13.01% 0.07x Within
2026-05-11 After-Close 20.59% 23.84% 1.16x Exceeded
2026-08-06 After-Close 55.56% 59.76% 1.08x Exceeded

Earnings calendar: this week’s reports with expected vs actual moves →

CVRX Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $8.90
7-DTE Move: $8.90
Days to Exp: 28 (2026-11-20)

Options Flow

Call Volume: 5
Put Volume: 0
P/C Volume: —
BULLISH
Call OI: 209
Put OI: 0
P/C OI: —
Total OI: 209

ATM Options Pricing

ATM Call: $2.40
ATM Put: $6.50
Call %: 37.8%
Put %: 102.4%

Chain Summary

Chain Volume: 364
Chain OI: 1,538
Last Updated: 10/23/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
LOW γ vs HISTORY

Estimated net dealer gamma is at the 15th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
15%
vs own history
GEX tilt
+0.02
OI-weighted, today
Vanna tilt
-0.21
δ-sensitivity to IV
Charm tilt
-0.59
δ-decay vs time
Charm tilt -0.59: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 5 ATM contracts, 1k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Oct 23 · No data
30 DTE / 10d —
— pts EXTREME
as of Oct 23 · ATM 519.7% / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$8.90Oct 23
Beta Analysis

Risk Metrics

Beta: 0.8392
Alpha: -136.40%
Correlation: 0.1015
R-Squared: 1.0%
Stock Volatility: 105.4%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own CVRX
4 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$1.2M
0.00%
#2229 of 3138+1091.7%13F
Citadel Hedge fund
Ken Griffin
$406K
0.00%
#4721 of 6285+196.7%13F
Point72 Hedge fund
Steve Cohen
$138K
0.00%
#1814 of 1945new13F
Millennium Management Hedge fund
Izzy Englander
$84K
0.00%
#3632 of 3716+20.3%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

CVRX Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 26,281,076 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

89 filers16,497,923 shares$87.09M value62.77% of float
# Filer Shares Value % of Total % of Float Period
1 JOHNSON & JOHNSON 4,024,861 $20.69M 23.76% 15.31% 2026-06-30
2 NEA Management Company, LLC 1,954,440 $10.05M 11.54% 7.44% 2026-06-30
3 Vanguard Group Inc Custodian 1,120,663 $7.96M 9.14% 4.26% 2025-12-31
4 BlackRock, Inc. Custodian 1,245,459 $6.40M 7.35% 4.74% 2026-06-30
5 Royal Bank of Canada Custodian 1,233,212 $6.34M 7.28% 4.69% 2026-06-30
6 GSK plc 1,007,583 $5.18M 5.95% 3.83% 2026-06-30
7 Vanguard Capital Management LLC 910,576 $4.68M 5.37% 3.46% 2026-06-30
8 SILVERCREST ASSET MANAGEMENT GROUP LLC 878,109 $4.51M 5.18% 3.34% 2026-06-30
9 Geode Capital Management, LLC Custodian 440,786 $2.27M 2.60% 1.68% 2026-06-30
10 PFM Health Sciences, LP 369,572 $1.90M 2.18% 1.41% 2026-06-30
11 State Street Corp 366,352 $1.88M 2.16% 1.39% 2026-06-30
12 RENAISSANCE TECHNOLOGIES LLC 230,000 $1.18M 1.36% 0.88% 2026-06-30
13 UBS Group AG Custodian 224,233 $1.15M 1.32% 0.85% 2026-06-30
14 TUDOR INVESTMENT CORP ET AL 205,684 $1.06M 1.21% 0.78% 2026-06-30
15 Goldman Sachs Group Inc Custodian 149,509 $768.48K 0.88% 0.57% 2026-06-30
16 Morgan Stanley Custodian 144,977 $745.18K 0.86% 0.55% 2026-06-30
17 Kestra Advisory Services, LLC 132,400 $680.54K 0.78% 0.50% 2026-06-30
18 Two Sigma Investments, LP Custodian 132,398 $680.53K 0.78% 0.50% 2026-06-30
19 Vanguard Fiduciary Trust Co 128,955 $662.83K 0.76% 0.49% 2026-06-30
20 Dimensional Fund Advisors LP Custodian 127,971 $659.87K 0.76% 0.49% 2026-06-30
21 Northern Trust Corp Custodian 124,767 $641.30K 0.74% 0.47% 2026-06-30
22 Vanguard Portfolio Management LLC 105,915 $544.40K 0.63% 0.40% 2026-06-30
23 AQR Capital Management, LLC Custodian 105,614 $542.86K 0.62% 0.40% 2026-06-30
24 Cresset Asset Management, LLC 103,849 $533.78K 0.61% 0.40% 2026-06-30
25 BNP Paribas Financial Markets Custodian 97,309 $500.17K 0.57% 0.37% 2026-06-30
4 filers$153.69K notional
# Filer Notional Value % of Total Period
1 Jane Street Group, LLC Custodian $69.39K 45.15% 2026-06-30
2 Citadel Advisors LLC Custodian $58.60K 38.13% 2026-06-30
3 Simplex Trading, LLC Custodian $19.02K 12.37% 2026-06-30
4 GROUP ONE TRADING LLC Custodian $6.68K 4.35% 2026-06-30
1 filers$2.57K notional
# Filer Notional Value % of Total Period
1 GROUP ONE TRADING LLC Custodian $2.57K 100.00% 2026-06-30

CVRX Insider Trading (Form 4)

Latest: 2026-08-13
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-13 Brent Binkowski CHIEF OPERATING OFFICER Buy (P) +26,223 $2.91 $76.4K EDGAR
2026-08-13 Brent Binkowski CHIEF OPERATING OFFICER Sell (S) −1,309 $2.55 -$3.3K EDGAR
2026-06-03 Mudit K. Jain Director Award (A) +8,720 — EDGAR
2026-06-03 Joseph P Slattery Director Award (A) +8,720 — EDGAR
2026-06-03 Kevin J. Ballinger Director Award (A) +8,720 — EDGAR
2026-06-03 Kirk G. Nielsen Director Award (A) +8,720 — EDGAR
2026-06-03 Mitch C. Hill Director Award (A) +8,720 — EDGAR
2026-06-03 Martha Shadan Director Award (A) +8,720 — EDGAR
2026-06-03 Michael D Dale Director Award (A) +29,005 — EDGAR
2026-03-16 Philip B. Adamson Chief Medical Officer Mixed +39,738 $7.90 -$10.0K EDGAR
2026-03-04 Gregory Morrison CHIEF HUMAN RESOURCES OFFICER Award (A) +34,000 — EDGAR
2026-03-03 Robert Allen John Chief Revenue Officer Mixed +31,036 $7.90 -$31.3K EDGAR
2026-03-03 Brent Binkowski CHIEF OPERATING OFFICER Award (A) +15,000 — EDGAR
2026-03-03 Kevin Hykes PRES & CEO Mixed +151,237 $7.90 -$61.3K EDGAR
2026-03-03 Paul Verrastro CHIEF MKTG & STRAT OFFICER Mixed +43,716 $7.90 -$10.1K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CVRX Insider Holdings

16 insiders · @ $1.42
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 & Johnson Johnson 10%+ Owner 4,040,861 $5.74M -$1.25M 3 2025-12-01
2 Johnson & Johnson Innovation - JJDC, Inc. 10%+ Owner 4,024,861 $5.72M -$660.4K 6 2026-01-08
3 Kirk G. Nielsen Director 1,918,854 $2.72M $2.71M 16 2026-06-03
4 Mudit K. Jain Director 994,553 $1.41M $4.37M 14 2026-06-03
5 Kevin Hykes PRES & CEO 284,237 $403.6K $213.6K 8 2026-03-03
6 Jared Oasheim CHIEF FINANCIAL OFFICER 98,447 $139.8K -$13.8K 9 2026-03-03
7 Robert Allen John Chief Revenue Officer 86,036 $122.2K -$31.3K 3 2026-03-03
8 Philip B. Adamson Chief Medical Officer 61,578 $87.4K -$10.0K 2 2026-03-16
9 Paul Verrastro CHIEF MKTG & STRAT OFFICER 60,551 $86.0K -$171.5K 13 2026-03-03
10 Joseph P Slattery Director 39,365 $55.9K $71.7K 14 2026-06-03
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

CVRX Board & Officers

As of SEC filings through Aug 13, 2026

Directors 8

Officers 6

10% owners 2

Changes in the last 10 years (40)
Jun 7, 2026The company announced the departure of Jared Oasheim as Chief Financial Officer in an SEC filing
Jun 1, 2026Michael D Dale became a director
Mar 2, 2026Gregory Morrison became Chief Human Resources Officer
Nov 10, 2025Johnson & Johnson Innovation - JJDC, Inc. first listed as a 10% owner in an SEC filing
Aug 11, 2025Brent Binkowski became Chief Operating Officer
Feb 4, 2025Philip B. Adamson became Chief Medical Officer
Sep 3, 2024Mitch C. Hill became a director
Sep 3, 2024Kevin J. Ballinger became a director
Aug 27, 2024The company announced the departure of Ali Behbahani from the board in an SEC filing
Jun 27, 2024Robert Allen John became Chief Revenue Officer
Feb 14, 2024Kevin Hykes first listed as Pres & CEO in an SEC filing
Feb 2, 2024Johnson & Johnson Innovation - JJDC, Inc. reported in an SEC filing no longer being a 10% owner
Feb 2, 2024Johnson & Johnson Innovation - JJDC, Inc. first listed as a 10% owner in an SEC filing
Jan 8, 2024The company announced the departure of Nadim Yared from the board in an SEC filing
Jan 8, 2024The company announced the departure of Nadim Yared as Chief Executive Officer in an SEC filing
Sep 18, 2023Johnson & Johnson Innovation - JJDC, Inc. reported in an SEC filing no longer being a 10% owner
Dec 21, 2022Kevin Hykes became a director
Aug 4, 2022Paul Verrastro listed as Chief Mktg & Strat Officer (previously Chief Marketing Officer) in SEC filings
Jan 21, 2022Craig E. Palmer became SVP, U.s. Sales
Jul 12, 2021Martha Shadan became a director
Not reported recently (9)
  • Craig E. Palmer · Last reported as SVP, U.s. Sales in an SEC filing dated Mar 27, 2024
  • Liz Galle · Last reported as VP of Global Clinical Research in an SEC filing dated Oct 18, 2023
  • Dean Bruhn-Ding · Last reported as VP of Reg. Affairs and QA in an SEC filing dated Aug 4, 2022
  • John M Nehra · Last reported as a director in an SEC filing dated Jun 9, 2022
  • John Brintnall · Last reported as Chief Strategy Officer and Sec in an SEC filing dated Apr 26, 2022
  • New Enterprise Associates 10 L P · Last reported as a 10% owner in an SEC filing dated Jul 7, 2021
  • Scott D Sandell · Last reported as a 10% owner in an SEC filing dated Jul 7, 2021
  • Nea Partners 10 L P · Last reported as a 10% owner in an SEC filing dated Jul 7, 2021
  • Geoffrey B Pardo · Last reported as a director in an SEC filing dated Jul 2, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

CVRX Proposed Insider Sales (Form 144)

Latest: 2024-11-29
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2024-11-29 Behbahani Ali Officer 21,837 $334.1K 2024-11-29 MORGAN STANLEY SMITH BARNEY LLC … — EDGAR
2024-11-19 PAUL VERRASTRO Officer 1,430 $19.4K 2024-11-19 Morgan Stanley Smith Barney LLC … — EDGAR
2024-11-18 Behbahani Ali Officer 9 $127 2024-11-18 MORGAN STANLEY SMITH BARNEY LLC … — EDGAR
2024-11-05 New Enterprise Associates VIII, LP Affiliate 171,071 $2.57M 2024-11-05 J.P. Morgan Securities LLC — EDGAR
2024-11-05 NEA Enterprise Associates 8A, LP Affiliate 173,388 $2.61M 2024-11-05 J.P. Morgan Securities LLC — EDGAR
2024-07-26 Palmer Craig E. Officer 18,243 $175.1K 2024-07-26 MORGAN STANLEY SMITH BARNEY LLC … — EDGAR
2024-07-25 Palmer Craig E. Officer 11,880 $113.9K 2024-07-25 MORGAN STANLEY SMITH BARNEY LLC … — EDGAR
2024-07-24 Palmer Craig E. Officer 2,000 $19.2K 2024-07-24 MORGAN STANLEY SMITH BARNEY LLC … — EDGAR
2024-07-23 Palmer Craig E. Officer 2,000 $20.1K 2024-07-23 Morgan Stanley Smith Barney LLC … — EDGAR
2024-07-22 Palmer Craig E. Officer 3,930 $37.7K 2024-07-22 MORGAN STANLEY SMITH BARNEY, LLC… — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
17 ETFs hold CVRX
17 shown · $2.54M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $1.2M — 2026-09-30
2 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.00% $495,792 $74.2B 2026-10-22
3 VXF Vanguard Extended Market ETF Vanguard 0.00% $357,933 — 2026-09-30
4 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.00% $215,361 $13.6B 2026-10-22
5 VTWO Vanguard Russell 2000 ETF Vanguard 0.00% $156,284 — 2026-09-30
6 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $64,650 $1.2B 2026-10-22
7 VTWG Vanguard Russell 2000 Growth ETF Vanguard 0.00% $30,496 — 2026-09-30
8 RSSL Global X Russell 2000 ETF Global X 0.00% $10,695 — 2026-10-23
9 IWV iShares Russell 3000 ETF iShares (BlackRock) 0.00% $7,317 $20.3B 2026-10-22
10 MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF Nport 0.00% $3,220 — 2026-05-31
11 VTHR Vanguard Russell 3000 ETF Vanguard 0.00% $2,083 — 2026-09-30
12 ITWO ProShares Russell 2000 High Income ETF ProShares 0.00% $1,245 — 2026-10-23
13 URTY ProShares UltraPro Russell2000 ProShares 0.00% $956 — 2026-10-23
14 UWM ProShares Ultra Russell2000 ProShares 0.00% $636 — 2026-10-23
15 EBI Longview Advantage ETF Nport 0.00% $123 — 2026-05-31
16 HDG ProShares Hedge Replication ETF ProShares 0.00% $27 — 2026-10-23
17 RB ProShares Russell 2000 Dynamic Buffer ETF ProShares 0.00% $11 — 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-1.97
TTM Revenue
$61.19M
TTM Net Income
$-51.97M
TTM Op. Cash Flow
$-40.46M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$15.71M$-14.04M$-0.53$-8.83M
Q1 '262026-03-31$14.77M$-13.12M$-0.50$-12.16M
Q4 '252025-12-31$16.02M$-11.93M$-0.45$-9.76M
Q3 '252025-09-30$14.69M$-12.87M$-0.49$-9.71M
Q2 '252025-06-30$13.59M$-14.74M$-0.57$-7.94M
Q1 '252025-03-31$12.35M$-13.77M$-0.53$-12.77M
Q4 '242024-12-31$15.34M$-10.65M$-0.40$-8.01M
Q3 '242024-09-30$13.37M$-13.10M$-0.57$-10.41M
Q2 '242024-06-30$11.81M$-14.03M$-0.65$-9.83M
Q1 '242024-03-31$10.77M$-22.19M$-1.04$-10.90M
Q4 '232023-12-31$11.30M$-9.16M$-0.44$-7.84M
Q3 '232023-09-30$10.51M$-9.01M$-0.43$-8.12M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-06
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.87
P/S
0.61
EV/EBITDA
—
EV/Sales
0.51
ROE
-260.5%
ROA
-56.3%
Div Yield
0.00%
FCF Yield
-108.41%
Debt/Equity
2.94
Current Ratio
—
Market Cap
$37.32M
as of 2026-10-23
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
1.98M
SI % of Float
14.15%
Days to Cover
2.40
Short Vol Ratio
42.7%
Free Float
14.01M
Float %
52.6%
Short interest 2026-09-30 • Short volume 2026-10-23 • Float 2026-08-24